R&D Systems Recombinant Human SorLA (aa 82-753) Protein, CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9880LA050
DescriptionThe Recombinant Human SorLA (aa 82-753) Protein is derived from HEK293. The Recombinant Human SorLA (aa 82-753) Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2 μm filtered solution in PBS.|
|12 months from date of receipt, ≤ -20°C as supplied; 1 month, 2 to 8°C under sterile conditions after reconstitution; 3 months, ≤ -20°C under sterile conditions after reconstitution.|
|<0.10 EU per 1 μg of the protein by the LAL method.|
|Reconstitute at 1 mg/mL in PBS.|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.|
|Human embryonic kidney cell, HEK293-derived human SorLA protein Ser82-Pro753, with a C-terminal 6-His tag|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok